[Severe hyperkalemia associated to the use of losartan and spironolactone: case report]

Rev Med Chil. 2005 Aug;133(8):947-52. doi: 10.4067/s0034-98872005000800012. Epub 2005 Sep 8.
[Article in Spanish]

Abstract

Hyperkalemia is a complications of the use of angiotensin converting enzyme inhibitors, angiotensin receptor antagonists and aldosterone antagonists. These drugs are commonly used for the treatment of hypertension and cardiac failure. We report a 84 year-old female treated with losartan 50 mg/day and spironolactone 25 mg/day that presented with a hyperkalemia of 8.4 mEq/l and bradicardia, drowsiness and respiratory depression. She required hemodialysis and ventilatory assistance. She was discharged in good conditions five days after admission.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Aged, 80 and over
  • Angiotensin II Type 1 Receptor Blockers / adverse effects*
  • Antihypertensive Agents / adverse effects*
  • Female
  • Humans
  • Hyperkalemia / chemically induced*
  • Hypertension / drug therapy
  • Losartan / adverse effects*
  • Severity of Illness Index
  • Spironolactone / adverse effects*

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Antihypertensive Agents
  • Spironolactone
  • Losartan